RA
Rosalind Advisors Portfolio holdings
AUM
$207M
This Quarter Return
-3.22%
1 Year Return
+62.29%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$126M
AUM Growth
+$126M
(+18%)
Cap. Flow
+$29.9M
Cap. Flow
% of AUM
23.67%
Top 10 Holdings %
Top 10 Hldgs %
61.47%
Holding
43
New
5
Increased
13
Reduced
5
Closed
1
Top Buys
| 1 |
Delcath Systems
DCTH
|
$9.44M |
| 2 |
Abeona Therapeutics
ABEO
|
$7.42M |
| 3 |
Cellectar Biosciences
CLRB
|
$5.21M |
| 4 |
Ocular Therapeutix
OCUL
|
$5.13M |
| 5 |
InspireMD
NSPR
|
$4.56M |
Top Sells
| 1 |
Veru
VERU
|
$1.52M |
| 2 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$1.41M |
| 3 |
Unicycive Therapeutics
UNCY
|
$155K |
| 4 |
Lyra Therapeutics
LYRA
|
$30.4K |
| 5 |
Kiora Pharmaceuticals
KPRX
|
$4 |
Sector Composition
| 1 | Healthcare | 100% |
